Xiangmin Tong

机构：Zhejiang Chinese Medical University, Westlake University, Zhejiang Provincial People's Hospital, Hangzhou First People's Hospital, Hangzhou Medical College · ORCID：0000-0002-4175-0321

发表论文 187 篇 · 总被引 5240 次 · h-index 33

代表论文

• Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial (2025 · Nature Cancer · 被引 58)
• DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target (2025 · Redox Biology · 被引 53)
• Overcoming the Delivery Challenges in CRISPR/Cas9 Gene Editing for Effective Cancer Treatment: A Review of Delivery Systems (2025 · International Journal of Medical Sciences · 被引 18)
• Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death (2025 · Redox Biology · 被引 16)
• Recent advances in phototherapy-based nanomedicine of lymphoma (2025 · Materials Today Bio · 被引 6)
• Tumor Pro-Senescence Strategy to Enhance Mild Photothermal Therapy of Diffuse Large B-Cell Lymphoma (2025 · ACS Applied Materials & Interfaces · 被引 5)